Age-related Macular Degeneration Market Size, Share, Growth, and Industry Analysis, By Type (Wet AMD,Dry AMD), By Application (Drugstore,Hospital,Others), Regional Insights and Forecast to 2035
Detailed TOC of Global Age-related Macular Degeneration Industry Trends Analysis Report 2025, Forecast to 2033 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Age-related Macular Degeneration Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Age-related Macular Degeneration Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Age-related Macular Degeneration Business Mode and Production Process
2.3.1 Age-related Macular Degeneration Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Age-related Macular Degeneration Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Age-related Macular Degeneration
2.4.2 Raw Material Cost of Age-related Macular Degeneration
2.4.3 Labor Cost of Age-related Macular Degeneration
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Age-related Macular Degeneration Revenue and Market Share by Manufacturer (2020-2025)
4.2 Global Age-related Macular Degeneration Sales Volume and Market Share by Manufacturer (2020-2025)
4.3 Global Age-related Macular Degeneration Price by Manufacturer (2020-2025)
4.4 Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Age-related Macular Degeneration, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Age-related Macular Degeneration, Product Offered and Application
4.7 Age-related Macular Degeneration Market Competitive Situation and Trends
4.7.1 Age-related Macular Degeneration Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Age-related Macular Degeneration Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Age-related Macular Degeneration Market Historical Development by Geographic Region (2020-2025)
5.1 Global Age-related Macular Degeneration Market Historical Sales Volume by Geographic Region (2020-2025)
5.2 Global Age-related Macular Degeneration Market Historical Revenue by Geographic Region (2020-2025)
5.3 North America Age-related Macular Degeneration Market Status by Country (2020-2025)
5.3.1 North America Age-related Macular Degeneration Sales Volume by Country (2020-2025)
5.3.2 North America Age-related Macular Degeneration Revenue by Country (2020-2025)
5.3.3 United States Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.3.4 Canada Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.4 Europe Age-related Macular Degeneration Market Status by Country (2020-2025)
5.4.1 Europe Age-related Macular Degeneration Sales Volume by Country (2020-2025)
5.4.2 Europe Age-related Macular Degeneration Revenue by Country (2020-2025)
5.4.3 Germany Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.4.4 France Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.4.5 United Kingdom Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.4.6 Spain Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.4.7 Russia Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.4.8 Poland Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.5 Asia Pacific Age-related Macular Degeneration Market Status by Country (2020-2025)
5.5.1 Asia Pacific Age-related Macular Degeneration Sales Volume by Country (2020-2025)
5.5.2 Asia Pacific Age-related Macular Degeneration Revenue by Country (2020-2025)
5.5.3 China Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.5.4 Japan Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.5.5 South Korea Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.5.6 Southeast Asia Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.5.7 India Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.5.8 Australia Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.6 Latin America Age-related Macular Degeneration Market Status by Country (2020-2025)
5.6.1 Latin America Age-related Macular Degeneration Sales Volume by Country (2020-2025)
5.6.2 Latin America Age-related Macular Degeneration Revenue by Country (2020-2025)
5.6.3 Mexico Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.6.4 Brazil Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.7 Middle East and Africa Age-related Macular Degeneration Market Status by Country (2020-2025)
5.7.1 Middle East and Africa Age-related Macular Degeneration Sales Volume by Country (2020-2025)
5.7.2 Middle East and Africa Age-related Macular Degeneration Revenue by Country (2020-2025)
5.7.3 GCC Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
5.7.4 South Africa Age-related Macular Degeneration Sales Volume, Revenue and Growth (2020-2025)
6 Global Age-related Macular Degeneration Market Historical Development by Product Type (2020-2025)
6.1 Age-related Macular Degeneration Definition by Type
6.2 Global Age-related Macular Degeneration Historical Sales Volume by Product Type (2020-2025)
6.3 Global Age-related Macular Degeneration Historical Revenue by Product Type (2020-2025)
6.4 Global Age-related Macular Degeneration Historical Price by Product Type (2020-2025)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2025)
6.5.1 Global Age-related Macular Degeneration Historical Sales Volume, Revenue and Growth Rate of Wet AMD (2020-2025)
6.5.2 Global Age-related Macular Degeneration Historical Sales Volume, Revenue and Growth Rate of Dry AMD (2020-2025)
7 Global Age-related Macular Degeneration Market Historical Development by End User (2020-2025)
7.1 Downstream Market Overview
7.2 Global Age-related Macular Degeneration Historical Sales Volume by End User (2020-2025)
7.3 Global Age-related Macular Degeneration Historical Revenue by End User (2020-2025)
7.4 Global Age-related Macular Degeneration Historical Price by End User (2020-2025)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2025)
7.5.1 Global Age-related Macular Degeneration Historical Sales Volume, Revenue and Growth Rate of Drugstore (2020-2025)
7.5.2 Global Age-related Macular Degeneration Historical Sales Volume, Revenue and Growth Rate of Hospital (2020-2025)
7.5.3 Global Age-related Macular Degeneration Historical Sales Volume, Revenue and Growth Rate of Others (2020-2025)
8 Leading Companies Profiles
8.1 F. Hoffmann-La Roche
8.1.1 F. Hoffmann-La Roche Corporation Information
8.1.2 F. Hoffmann-La Roche - Age-related Macular Degeneration Product Portfolio and Specification
8.1.3 F. Hoffmann-La Roche Performance Analysis (2020-2025)
8.1.4 F. Hoffmann-La Roche Business and Markets Served
8.1.5 F. Hoffmann-La Roche Recent Developments
8.2 Iconic Therapeutics
8.2.1 Iconic Therapeutics Corporation Information
8.2.2 Iconic Therapeutics - Age-related Macular Degeneration Product Portfolio and Specification
8.2.3 Iconic Therapeutics Performance Analysis (2020-2025)
8.2.4 Iconic Therapeutics Business and Markets Served
8.2.5 Iconic Therapeutics Recent Developments
8.3 Ohr Pharmaceutical
8.3.1 Ohr Pharmaceutical Corporation Information
8.3.2 Ohr Pharmaceutical - Age-related Macular Degeneration Product Portfolio and Specification
8.3.3 Ohr Pharmaceutical Performance Analysis (2020-2025)
8.3.4 Ohr Pharmaceutical Business and Markets Served
8.3.5 Ohr Pharmaceutical Recent Developments
8.4 Regeneron Pharmaceuticals
8.4.1 Regeneron Pharmaceuticals Corporation Information
8.4.2 Regeneron Pharmaceuticals - Age-related Macular Degeneration Product Portfolio and Specification
8.4.3 Regeneron Pharmaceuticals Performance Analysis (2020-2025)
8.4.4 Regeneron Pharmaceuticals Business and Markets Served
8.4.5 Regeneron Pharmaceuticals Recent Developments
8.5 Neurotech Pharmaceuticals
8.5.1 Neurotech Pharmaceuticals Corporation Information
8.5.2 Neurotech Pharmaceuticals - Age-related Macular Degeneration Product Portfolio and Specification
8.5.3 Neurotech Pharmaceuticals Performance Analysis (2020-2025)
8.5.4 Neurotech Pharmaceuticals Business and Markets Served
8.5.5 Neurotech Pharmaceuticals Recent Developments
8.6 Allergan
8.6.1 Allergan Corporation Information
8.6.2 Allergan - Age-related Macular Degeneration Product Portfolio and Specification
8.6.3 Allergan Performance Analysis (2020-2025)
8.6.4 Allergan Business and Markets Served
8.6.5 Allergan Recent Developments
8.7 Bausch+Lomb
8.7.1 Bausch+Lomb Corporation Information
8.7.2 Bausch+Lomb - Age-related Macular Degeneration Product Portfolio and Specification
8.7.3 Bausch+Lomb Performance Analysis (2020-2025)
8.7.4 Bausch+Lomb Business and Markets Served
8.7.5 Bausch+Lomb Recent Developments
8.8 Novartis
8.8.1 Novartis Corporation Information
8.8.2 Novartis - Age-related Macular Degeneration Product Portfolio and Specification
8.8.3 Novartis Performance Analysis (2020-2025)
8.8.4 Novartis Business and Markets Served
8.8.5 Novartis Recent Developments
8.9 Gilead Sciences
8.9.1 Gilead Sciences Corporation Information
8.9.2 Gilead Sciences - Age-related Macular Degeneration Product Portfolio and Specification
8.9.3 Gilead Sciences Performance Analysis (2020-2025)
8.9.4 Gilead Sciences Business and Markets Served
8.9.5 Gilead Sciences Recent Developments
8.10 Bayer HealthCare
8.10.1 Bayer HealthCare Corporation Information
8.10.2 Bayer HealthCare - Age-related Macular Degeneration Product Portfolio and Specification
8.10.3 Bayer HealthCare Performance Analysis (2020-2025)
8.10.4 Bayer HealthCare Business and Markets Served
8.10.5 Bayer HealthCare Recent Developments
8.11 Alcon
8.11.1 Alcon Corporation Information
8.11.2 Alcon - Age-related Macular Degeneration Product Portfolio and Specification
8.11.3 Alcon Performance Analysis (2020-2025)
8.11.4 Alcon Business and Markets Served
8.11.5 Alcon Recent Developments
8.12 Avalanche
8.12.1 Avalanche Corporation Information
8.12.2 Avalanche - Age-related Macular Degeneration Product Portfolio and Specification
8.12.3 Avalanche Performance Analysis (2020-2025)
8.12.4 Avalanche Business and Markets Served
8.12.5 Avalanche Recent Developments
9 Global Age-related Macular Degeneration Market Forecast by Product Type and End User (2025-2033)
9.1 Global Age-related Macular Degeneration Market Forecast by Product Type (2025-2033)
9.1.1 Global Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth Rate of Wet AMD (2025-2033)
9.1.2 Global Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth Rate of Dry AMD (2025-2033)
9.2 Global Age-related Macular Degeneration Market Forecast by End User (2025-2033)
9.2.1 Global Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth Rate of Drugstore (2025-2033)
9.2.2 Global Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth Rate of Hospital (2025-2033)
9.2.3 Global Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth Rate of Others (2025-2033)
10 Global Age-related Macular Degeneration Market Forecast by Geographic Region (2025-2033)
10.1 Global Age-related Macular Degeneration Sales Volume and Revenue Forecast by Geographic Region (2025-2033)
10.2 North America Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.2.1 United States Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.2.2 Canada Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3 Europe Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.1 Germany Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.2 France Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.3 United Kingdom Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.4 Spain Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.5 Russia Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.3.6 Poland Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4 Asia Pacific Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.1 China Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.2 Japan Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.3 South Korea Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.4 Southeast Asia Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.5 India Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.4.6 Australia Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5 Latin America Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5.1 Mexico Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.5.2 Brazil Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6 Middle East and Africa Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6.1 GCC Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
10.6.2 South Africa Age-related Macular Degeneration Sales Volume, Revenue Forecast and Growth (2025-2033)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer